F. Mazingue

发表

Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours

Y. Bertrand, J. van der Werff Ten Bosch, A. Uyttebroeck, 2011, Pediatric blood & cancer.

Growth deceleration in children treated with imatinib for chronic myeloid leukaemia.

A. Baruchel, T. Leblanc, Y. Bertrand, 2014, European journal of cancer.

l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial

H. Dombret, A. Baruchel, P. Chevallier, 2011, British journal of haematology.

[Hodgkin disease and autoimmunity in children: 11 case reports].

Y. Bertrand, C. Paillard, A. Pagnier, 2011, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.

Y. Bertrand, F. Méchinaud, S. Suciu, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

H. Cavé, P. Rohrlich, Y. Bertrand, 2017, Haematologica.

The EORTC Children's Leukemia Group: Preclinical and clinical research and resulting achievements

H. Cavé, Y. Bertrand, P. Rohrlich, 2012 .

The French version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).

F. Guillemin, A. Leplège, J. Pouchot, 2001, Clinical and Experimental Rheumatology.

Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.

H. Cavé, Y. Bertrand, A. Uyttebroeck, 2008, European journal of cancer.

Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

C. Flamant, G. Leverger, M. Labopin, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951

E. Clappier, H. Cavé, P. Kastner, 2015, Leukemia.

Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG).

Y. Bertrand, C. Rubie, P. Lutz, 1996, Bone marrow transplantation.

Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?

A. Duhamel, E. Thébaud, A. Martinot, 2015, Journal of pediatric hematology/oncology.

Predicting the risk of severe bacterial infection in children with chemotherapy‐induced febrile neutropenia

E. Thébaud, A. Martinot, P. Leblond, 2010, Pediatric blood & cancer.

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

G. Leverger, M. Labopin, C. Preudhomme, 2010, Leukemia.

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.

J. Cayuela, A. Baruchel, Y. Bertrand, 2014, Blood.

Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience

J. Cayuela, H. Dombret, E. Macintyre, 2010, Leukemia.

CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol

F. Speleman, E. Clappier, J. Philippé, 2015, Haematologica.

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.

H. Cavé, Y. Bertrand, A. Uyttebroeck, 2021, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Results of successive EORTC‐CLG 58 881 and 58 951 trials in paediatric T‐cell acute lymphoblastic leukaemia (ALL)

H. Cavé, Y. Bertrand, P. Rohrlich, 2019, British journal of haematology.

p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia

B. Quesnel, P. Fenaux, F. Bauters, 2002 .

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

É. Oksenhendler, W. Vainchenker, T. Leblanc, 2018, Blood.

Socio‐economic outcomes among long‐term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study

P. Rohrlich, G. Rossi, J. van der Werff Ten Bosch, 2022, European journal of cancer care.

Improved outcome with pulses of Vincristine (VCR) and Steroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and Non Hodgkin Lymphoma (NHL): final report of the EORTC randomized phase III trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .

Gastrostomy as a Decompression Technique in Children With Chronic Gastrointestinal Obstruction

L. Michaud, D. Turck, D. Guimber, 2001, Journal of pediatric gastroenterology and nutrition.

Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.

R. Dessein, A. Martinot, F. Mazingue, 2019, The Journal of infection.

Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.

F. Millot, H. Rubié, A. Thyss, 1994, Leukemia & lymphoma.

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

K. Norga, E. Clappier, H. Cavé, 2018, Leukemia.

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

P. Maes, Y. Bertrand, J. van der Werff Ten Bosch, 2005, Leukemia.

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report

S. Loridant, B. Sendid, B. Bruno, 2018, BMC Pharmacology and Toxicology.

Changes of Cerebral Biopterin and Biogenic Amine Metabolism in Leukemic Children Receiving 5 g/m2 Intravenous Methotrexate

P. Ingrand, F. Guilhot, F. Millot, 1995, Pediatric Research.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Valérie Rigau, Valérie Taly, Christine Bodemer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients.

T. Molina, F. Rieux-Laucat, A. Fischer, 2020, The journal of allergy and clinical immunology. In practice.

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

H. Cavé, N. Dastugue, A. Uyttebroeck, 2014, Haematologica.

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.

F. Speleman, A. Hagemeijer, H. Cavé, 2004, Blood.

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

F. Speleman, E. Clappier, H. Cavé, 2010, Leukemia.

Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

E. Clappier, H. Cavé, P. Rohrlich, 2015, Annals of Hematology.

Chromosomal insertion involving MLL in childhood acute myeloblastic leukemia (M4).

C. Preudhomme, J. Andrieux, J. Laï, 2004, Cancer genetics and cytogenetics.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.

N. Dastugue, A. Uyttebroeck, S. Suciu, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A case of adrenal haemorrhage after minor trauma in a young child: think of neuroblastoma.

M. Bonnevalle, P. Leblond, B. Nelken, 2006, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

Severe combined immunodeficiency syndrome associated with autosomal recessive familial multiple gastrointestinal atresias: study of a family.

F. Gottrand, D. Turck, C. Ricour, 1990, American journal of medical genetics.

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

Y. Bertrand, S. Suciu, Y. Benoît, 1994, British journal of haematology.

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort

F. Rieux-Laucat, A. Fischer, G. Leverger, 2015, Front. Pediatr..

Long‐term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study

P. Rohrlich, Y. Bertrand, J. van der Werff Ten Bosch, 2019, British journal of haematology.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

K. Hoang-Xuan, G. Leverger, A. Idbaih, 2018, British journal of haematology.

Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC).

P. Rohrlich, Y. Bertrand, F. Guilhot, 1997, Pediatrics.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

F. Rieux-Laucat, A. Fischer, J. Jais, 2019, Journal of Clinical Immunology.

Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment.

C. Garel, M. Polak, F. Doz, 2004, The Journal of clinical endocrinology and metabolism.

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

F. Rieux-Laucat, A. Fischer, J. Jais, 2017, The Journal of allergy and clinical immunology.

Burden of Poor Health Conditions and Quality of Life in 656 Children with Primary Immunodeficiency

A. Fischer, P. Auquier, C. Picard, 2017, The Journal of pediatrics.

Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) study

A. Fischer, P. Auquier, C. Picard, 2017, The Journal of allergy and clinical immunology.

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

A. Trkola, P. Tovey, C. Königs, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

A. Fischer, R. Tubiana, L. Cravello, 2020, The Journal of antimicrobial chemotherapy.

Continuous Infusion of Ceftazidime in the Empiric Treatment of Febrile Neutropenic Children With Cancer

J. Dalle, B. Nelken, F. Mazingue, 2002, Journal of pediatric hematology/oncology.

Optimization of Continuous Infusion of Piperacillin–Tazobactam in Children With Fever and Neutropenia

R. Dessein, R. Courcol, F. Wallet, 2013, The Pediatric infectious disease journal.

Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes

L. Abenhaim, G. Leverger, T. Leblanc, 2017, Pediatric blood & cancer.

Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency.

A. Fischer, C. Picard, S. Pannier, 2019, The Journal of allergy and clinical immunology.

Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.

F. Gottrand, B. Nelken, F. Mazingue, 1997, Journal of pediatric gastroenterology and nutrition.

Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study.

F. Gottrand, D. Turck, S. Ategbo, 1997, The American journal of clinical nutrition.

Signal-Averaged Electrocardiography in Children with Anthracycline-Induced Cardiomyopathy

A. Duhamel, C. Kouakam, G. Vaksmann, 2001, Pediatric Cardiology.

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

H. Cavé, P. Rohrlich, Y. Bertrand, 2012 .

Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis.

F. Guillemin, J. Pouchot, C. Guyot, 2002, Joint, bone, spine : revue du rhumatisme.

Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis

Alain Martinot, François Dubos, A. Martinot, 2014, Pediatric blood & cancer.

Still looking for the best variables for decision rules in childhood febrile neutropenia

A. Martinot, F. Mazingue, F. Dubos, 2011 .

Fertility Status Among Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled Between 1971 and 1998 in the EORTC Children Leukemia Group Trials 58741, 58831/2 and 58881

P. Rohrlich, A. Uyttebroeck, R. Paulus, 2017 .

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

P. Rohrlich, Y. Bertrand, A. Uyttebroeck, 2016 .

Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL

I. Yakoub-Agha, C. Preudhomme, A. Decouvelaere, 2003, Leukemia.

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2009 .

Congenital acute monoblastic leukemia with double translocation (8;16) (p11;p13) and (16;20) (q13;p13).

M. Zandecki, J. Laï, O. Chassaing, 1988, Nouvelle revue francaise d'hematologie.

Treatment outcome in infant acute lymphoblastic leukemia

A. Uyttebroeck, S. Suciu, Y. Benoît, 2000 .

Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer.

A. Uyttebroeck, S. Suciu, Y. Benoît, 2000, Blood.

Prognostic Significance of NOTCH1 and FBXW7 Mutations in Childhood T-Cell Acute Lymphoblastic Leukemia (T-ALL): Results From the EORTC Children Leukemia Group.

F. Speleman, E. Clappier, H. Cavé, 2009 .

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

H. Cavé, P. Rohrlich, Y. Bertrand, 2012 .

Clinical activity of ERY001 (erythrocyte encapsulated l-asparaginase) and native l-asparaginase (L-ASP) in combination with COOPRALL regimen in phase III randomized trial in patients with relapsed acute lymphoblastic leukemia (ALL).

A. Baruchel, J. Stéphan, X. Thomas, 2015 .

Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.

F. Bauters, J. Harousseau, F. Millot, 1993, Leukemia and Lymphoma.

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2010 .

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .